| Schedule of Basic and Diluted Net (Loss) Income Per Share Attributable to Common and Limited Stockholders |
The following table presents the calculation of basic and diluted net income (loss) per share attributable to common and limited common stockholders for the periods presented (in thousands, except for share and per share data): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Numerator: | | | | | | | | | Net income (loss) attributable to Schrödinger common and limited common stockholders | $ | 5,975 | | | $ | (43,173) | | | $ | (54,051) | | | $ | (102,981) | | | Denominator: | | | | | | | | | Weighted average shares used to compute net income (loss) per share of common and limited common stockholders, basic: | 74,712,581 | | 73,427,635 | | 74,352,857 | | 73,243,797 | | Effect of the exercise of common stock options and vested RSUs on weighted average common and limited common shares | 1,056,779 | | | — | | | — | | | — | | | Weighted average shares used to compute net income (loss) per share of common and limited common stockholders, diluted: | 75,769,360 | | | 73,427,635 | | | 74,352,857 | | | 73,243,797 | | | | | | | | | | | Net income (loss) per share of common and limited common stockholders, basic: | $ | 0.08 | | | $ | (0.59) | | | $ | (0.73) | | | $ | (1.41) | | | Net income (loss) per share of common and limited common stockholders, diluted: | $ | 0.08 | | | $ | (0.59) | | | $ | (0.73) | | | $ | (1.41) | |
|
| Schedule of Potentially Dilutive Securities not Included in Diluted Per Share Calculations Anti-dilutive |
Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Shares subject to outstanding common stock options | 11,024,045 | | 12,578,030 | | 12,039,280 | | 12,578,030 | | Shares subject to outstanding unvested RSUs and PRSUs | 1,565,956 | | 2,472,402 | | 3,165,741 | | 2,472,402 | | Total shares subject to outstanding common stock options and unvested RSUs and PRSUs | 12,590,001 | | 15,050,432 | | 15,205,021 | | 15,050,432 |
|